Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Lehrbeauftragte/r, Klinik für Urologie
Aktuelle Veranstaltungen
-
2023 SS
Vergangene Veranstaltungen (max. 10)
-
2022 WS
-
2022 SS
-
2021 WS
-
2021 SS
-
2020 WS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Epiregulin expression and secretion is increased in castration-resistant prostate cancerIn: Frontiers in Oncology Jg. 13 (2023)ISSN: 2234-943XOnline Volltext: dx.doi.org/ (Open Access)
-
High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancerIn: Prostate Cancer and Prostatic Diseases Jg. 25 (2022) Nr. 3, S. 484 - 490ISSN: 1365-7852; 1476-5608Online Volltext: dx.doi.org/ (Open Access)
-
Newly Diagnosed Oligometastatic Prostate Cancer : Current Controversies and Future DevelopmentsIn: European Urology Oncology Jg. 5 (2022) Nr. 5, S. 587 - 600ISSN: 2588-9311Online Volltext: dx.doi.org/
-
Increased expression of akt3 in neuroendocrine differentiated prostate cancer cells alters the response towards anti‐androgen treatmentIn: Cancers Jg. 13 (2021) Nr. 3, S. 578ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Patient-derived xenografts and organoids model therapy response in prostate cancerIn: Nature Communications Jg. 12 (2021) Nr. 1, S. 1117ISSN: 2041-1723Online Volltext: dx.doi.org/ (Open Access)
-
Small Molecular Inhibitors Block TRPM4 Currents in Prostate Cancer Cells, with Limited Impact on Cancer Hallmark FunctionsIn: Journal of Molecular Biology (JMB) Jg. 433 (2021) Nr. 17,ISSN: 1089-8638; 0022-2836Online Volltext: dx.doi.org/ (Open Access)
-
MiR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivoIn: BMC Cancer Jg. 19 (2019) Nr. 1, S. 627ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access)
-
Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratificationIn: BMC Cancer Jg. 19 (2019) Nr. 1, S. 1216ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access)
-
Behandlung des fortgeschrittenen Prostatakarzinoms : Eine interdisziplinäre EmpfehlungIn: Praxis Jg. 107 (2018) Nr. 19, S. 1043 - 1051ISSN: 1661-8165; 1661-8157Online Volltext: dx.doi.org/
-
Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centersIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) Jg. 95 (2010) Nr. 11, S. 4925 - 4932ISSN: 0021-972X; 1945-7197Online Volltext: dx.doi.org/
-
Multiparametric Magnetic Resonance Imaging for Prostate-specific Antigen Recurrence After Radical Prostatectomy : Are We Leaving the “One Treatment Fits All Approach” and Moving Towards Personalized Imaging-guided Treatment?In: European Urology Jg. 73 (2018) Nr. 6, S. 888 - 889ISSN: 0302-2838; 0302-2838Online Volltext: dx.doi.org/
-
Perioperative chemoimmunotherapy with durvalumab for operable muscle-invasive urothelial carcinoma (MIUC) : Primary analysis of the single arm phase II trial SAKK 06/17In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 16_Suppl., S. 4515ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Management of Nonmetastatic Failure Following Local Prostate Cancer TherapyIn: Urologic Oncology / Merseburger, Axel S.; Burger, Maximilian 2019, S. 227 - 240ISBN: 9783319426235; 9783319426228Online Volltext: dx.doi.org/